About MediBeacon
MediBeacon is a company based in St. Louis (United States) founded in 2011 by Richard Dorshow and Steve Hanley. MediBeacon has raised $110.71 million across 12 funding rounds from investors including HHS, Huadong Medicine and St Louis City Health Dept. MediBeacon has completed 1 acquisition, including Mannheim Pharma & Diagnostics. MediBeacon operates in a competitive market with competitors including Physidia, Utopic Tech, FAST BioMedical, Accunea and Uro Bionics, among others.
- Headquarter St. Louis, United States
- Founders Richard Dorshow, Steve Hanley
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$110.71 M (USD)
in 12 rounds
-
Latest Funding Round
$16.09 M (USD), Series D
Aug 31, 2023
-
Investors
HHS
& 6 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of MediBeacon
Unlock access to complete
Unlock access to complete
Funding Insights of MediBeacon
MediBeacon has successfully raised a total of $110.71M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $16.09 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MediBeacon
MediBeacon has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Huadong Medicine and St Louis City Health Dept.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies focused VC firm operating across Missouri
|
Locked | Locked | Locked | |
|
Private equity firm focused on acquisitions
|
Locked | Locked | Locked | |
|
Venture capital and acceleration are provided to life science startups.
|
Locked | Locked | Locked |
Investor details for MediBeacon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MediBeacon
MediBeacon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mannheim Pharma & Diagnostics.
Investment portfolio details for MediBeacon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of diagnostic solutions for gastrointestinal microbial assessment and measurement
|
Locked | Locked | 0 | Locked |
Complete acquisition details for MediBeacon
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - MediBeacon
Detailed financials for MediBeacon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medibeacon Comparisons
Peer comparison for MediBeacon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MediBeacon
MediBeacon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Physidia, Utopic Tech, FAST BioMedical, Accunea and Uro Bionics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of a hemodialysis monitoring device
|
|
| Locked | Locked | Locked |
Medical device for kidney diagnosis and management is developed.
|
|
| Locked | Locked | Locked |
Develops fluorescent in-vivo markers for measuring plasma volume and mGFR.
|
|
| Locked | Locked | Locked |
Monitoring devices for kidney function are developed by Accunea.
|
|
| Locked | Locked | Locked |
Develops innovative devices for bladder monitoring in urology.
|
Detailed competitors of MediBeacon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medibeacon
Complete news archive for MediBeacon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MediBeacon
MediBeacon was founded in 2011 and raised its 1st funding round 2 years after it was founded.
MediBeacon is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Steve Hanley is the current CEO of MediBeacon. They have also founded this company.
MediBeacon is a funded company, having raised a total of $110.71M across 12 funding rounds to date.
MediBeacon is an optical diagnostic company that focuses on providing clinicians with critical patient information. MediBeacon creates light-activated agents, for non-invasive real-time kidney function monitoring system is in human clinical trials. Optical Renal Function Monitor (ORFM) is companys first product platform. This system is focused on real-time monitoring of kidney function. The company claims to hold multiple patents on its light-activated agents and has products for Nephrology and Gastroenterology in pipeline as on Dec15. Real-time point-of-care measurement of renal function is used to improve patient outcomes in the ICU and the operating suite and to achieve optimal dosing strategies for nephrotoxic drug interventions such as chemotherapeutics and imaging contrast agents.
MediBeacon's top competitors include Physidia, Utopic Tech and Prantae Solutions.
MediBeacon has made 1 acquisition, including Mannheim Pharma & Diagnostics.
MediBeacon has 7 investors. Key investors include HHS, Huadong Medicine, St Louis City Health Dept, Helix Investments, and HC2 Holdings.